Cablivi (Caplacizumab-yhdp) Injection
Cablivi (Caplacizumab-yhdp) – thrombotic thrombocytopenic purpura (aTTP) drug therapy in India.
CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
| Brand Name: | Cablivi |
| Generic Name: | Caplacizumab-yhdp Injection |
| Strength: | • For injection: 11 mg as a lyophilized powder in a single-dose vial. |
| Manufacturer: | Ablynx US |
| Approved By: | EMA, USFDA |
Source Details: Patient Information.
Cablivi must always be used under the supervision of a Registered Medical Practitioner (RMP).
Access Cablivi for aTTP on a Named Patient Import Basis
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Cablivi (Caplacizumab-yhdp) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).
For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.
Contact Info
CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
Caplacizumab, sold under the brand name Cablivi, is a monoclonal antibody used for the treatment of thrombotic thrombocytopenic purpura. Caplacizumab is indicated for the treatment of acquired thrombotic thrombocytopenic purpura, in combination with plasma exchange and immunosuppressive therapy.
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disorder that is even more uncommon in children, only occurring in about 1 per 10 million children annually. aTTP causes blood clots in the small blood vessels. These clots can slow or block the flow of blood to parts of the heart, brain, kidneys, and other organs. In this disorder, platelets (blood cells involved in clotting) clump together, leaving fewer platelets in the rest of the body to help with clotting. In addition, red blood cells may break apart, causing anemia.
CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use
Initial U.S. Approval: 2019
Contact IPN – Cablivi Access in India
For inquiries regarding availability, import process, or cost of Cablivi (Caplacizumab-yhdp) Injection :
India Pharma Network (IPN) : Headquartered in New Delhi, with branch offices in Delhi, Gurugram, Mumbai, Bangalore, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur and Lucknow, IPN supports medicine imports across India on a Named Patient Import Basis and for personal use only. Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774. Email: info@indianpharmanetwork.co.in
NEWS/UPDATES
- FDA approves therapy for rare blood disorder in pediatric patients 12 years and older.
- FDA approved caplacizumab-yhdp.
- FDA approves caplacizumab for pediatric acquired thrombotic thrombocytopenic purpura.
- FDA approves Sanofi’s Cablivi as first therapy for rare blood disorder.
Compliance & Disclaimer
India Pharma Network acts solely as a facilitator for Cablivi (Caplacizumab-yhdp) Injection access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:
- Strictly on a Named Patient Import Basis
- Exclusively for personal use
- Not for resale, distribution, or commercial sale
- Subject to applicable Indian laws and regulatory approvals
The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.
Steps to get access
If you possess a prescription issued by a Registered Medical Practitioner (RMP), IPN in Delhi can aid you in acquiring authentic medication globally. Our experts will furnish you with a detailed, step-by-step guidance on the lawful and secure process of importing prescription medicines based on the particulars you provide.
Step 1. Send a request for your medicine online:-
Applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
Step 2. Verification of documents:-
We verify your a prescription and necessary documents to import drugs in small quantities for personal use.
Step 3. Permission to Import:-
After getting approval of Drugs Controller General (India), we start the process to import of drugs as mentioned in prescription for personal use.
Step 4. We source your medicine:-
Our expert sourcing team work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.
Step 5. Delivery of medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.
Documentation Required
Doctor’s Prescription –
We would require prescription from Registered Medical Practitioner (RMP) stating product name, dosage, duration of treatment and diagnosis.
Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.
Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process.
FAQs
Who Can Access Cablivi (Caplacizumab-yhdp) Injection in India?
IPN facilitates access to Cablivi for:
- Patients prescribed Cablivi by their oncologist
- Doctors and treating physicians seeking access for patients
- Hospitals and oncology centers managing lung cancer therapies
All imports are patient-specific and cannot be used for commercial purposes.
How to Import Cablivi (Caplacizumab-yhdp) Injection to India
- Valid Prescription: Must be issued by a Registered Medical Practitioner (RMP)
- Form 12A Application: Required by Indian regulatory authorities for medicine import
- Supporting Medical Documentation: As applicable for approval
India Pharma Network (IPN) assists with:
- Preparing and submitting documentation
- Liaising with regulatory authorities
- Coordinating import and delivery
Why IPN?
India Pharma Network (IPN) helps patients, doctors, and hospitals import medicines to India that are not readily available in the domestic market. With over 10 years of experience, IPN provides end-to-end facilitation for accessing specialized, orphan, and life-saving medicines, strictly in compliance with Indian regulations.
Why Choose India Pharma Network in India?
- 10+ years of experience in importing specialty medicines in India
- Expertise in lung cancer and oncology therapies
- Nationwide presence with offices in Delhi, Kolkata, and Mumbai
- Strict adherence to Named Patient Basis regulations
- Transparent, patient-focused service
How to get access prescriptions drugs in India?
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
Contact Details
Indian Pharma Network
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
info@indianpharmanetwork.co.in
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in